Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth

Crissy Dudgeon(Rutgers, The State University of New Jersey), Lin Zhang(Qingdao University), P Wang(UPMC Hillman Cancer Center), Anne Sebastiani(University Medical Center of the Johannes Gutenberg University Mainz), Jian Yu(UPMC Hillman Cancer Center), Rui Yun Peng(Hubei University of Chinese Medicine)
Oncogene
January 30, 2012
Cited by 65


Related Papers